Nanomedicines for back of the eye drug delivery, gene delivery, and imaging

UB Kompella, AC Amrite, RP Ravi… - Progress in retinal and eye …, 2013 - Elsevier
Abstract Treatment and management of diseases of the posterior segment of the eye such
as diabetic retinopathy, retinoblastoma, retinitis pigmentosa, and choroidal …

Recent applications of liposomes in ophthalmic drug delivery

GP Mishra, M Bagui, V Tamboli… - Journal of drug …, 2011 - Wiley Online Library
Liposomal formulations were significantly explored over the last decade for the ophthalmic
drug delivery applications. These formulations are mainly composed of phosphatidylcholine …

Nanotherapy for posterior eye diseases

IP Kaur, S Kakkar - Journal of Controlled Release, 2014 - Elsevier
It is assumed that more than 50% of the most enfeebling ocular diseases have their origin in
the posterior segment. Furthermore, most of these diseases lead to partial or complete …

New techniques for drug delivery to the posterior eye segment

E Eljarrat-Binstock, J Pe'er, AJ Domb - Pharmaceutical research, 2010 - Springer
Ocular drug delivery has become an increasingly important field of research especially
when treating posterior segment diseases of the eye, such as age-related macular …

Recent trends in drug-delivery systems for the treatment of diabetic retinopathy and associated fibrosis

M Silva, T Peng, X Zhao, S Li, M Farhan… - Advanced Drug Delivery …, 2021 - Elsevier
Diabetic retinopathy is a frequent microvascular complication of diabetes and a major cause
of visual impairment. In advanced stages, the abnormal neovascularization can lead to …

Non-invasive strategies for targeting the posterior segment of eye

A Madni, MA Rahem, N Tahir, M Sarfraz, A Jabar… - International journal of …, 2017 - Elsevier
The safe and effective treatment of eye diseases has been remained a global myth. Several
advancements have been done and various drug delivery and treatment techniques have …

Combined photodynamic therapy and intravitreal triamcinolone for choroidal neovascularization secondary to punctate inner choroidopathy or of idiopathic origin: one …

WM Chan, TYY Lai, TTY Lau, VYW Lee, DTL Liu… - Retina, 2008 - journals.lww.com
Purpose: To evaluate the efficacy and safety of combined intravitreal triamcinolone (IVTA)
and photodynamic therapy (PDT) with verteporfin in the treatment of subfoveal choroidal …

Drug, delivery and devices for diabetic retinopathy (3Ds in DR)

J Nirmal, K Radhakrishnan, M Moreno… - Expert Opinion on …, 2016 - Taylor & Francis
ABSTRACT Introduction: Diabetic Retinopathy (DR) is one of the most common causes of
blindness among the working population worldwide. Clearly, there is an unmet clinical need …

Serum inflammatory factors in patients with idiopathic choroidal neovascularization

F Yang, HL Dou, Z Ma, YL Li, XR Lu… - Ocular immunology …, 2010 - Taylor & Francis
Objective: To investigate serum inflammatory factors in patients with idiopathic choroidal
vascularization (CNV), including vascular endothelial growth factor (VEGF), tumor necrosis …

[PDF][PDF] Current role of photodynamic therapy in ophthalmic practice

P Rishi, V Agarwal - Sci J Med & Vis Res Foun, 2015 - visionresearchfoundation.org
Introduction Photodynamic therapy (PDT) is a form of lighttherapy using light-sensitive
compounds that when exposed to light selectively become toxic to targeted cells …